« All Events

  • This event has passed.

2024 OSPA Lane County Seminar

March 2 - March 3

Join us for the 2024 OSPA Lane County Seminar on March 2-3!We will once again be back at the Graduate Hotel for the conference with 15 CE hours and lots of social time together! We have a room block for our group, but you need to make reservations by February 1st. The Graduate Hotel room reservations can be made through their reservations line 844-888-4723 and referring to booking code 322024OS

 Or via the booking link:  OSPA Lane County Mid-Winter CE Seminar 2023

The Early Bird deadline to receive a discount on the registration fee is also on February 1st. Be sure to reserve your spot early to save money. OSPA members receive discounted registration fees for all CE conferences as part of your membership. By joining OSPA you OSPA you can take advantage of the many benefits we offer: legislative advocacy, discounted continuing education opportunities, our e-newsletters, networking opportunities, OSPA’s website, Facebook, LinkedIn, Twitter and more. Join OSPA today by following this link https://oregonpharmacy.app.neoncrm.com/np/clients/oregonpharmacy/membershipJoin.jsp

 

REGISTER NOW

 

Saturday, March 2, 2024

Time Presentation Title UAN Name
8:00 am Leveraging Technology in Diabetes Management: A Guide to Continuous Glucose Monitoring (CGM) (See below) Natalia Puccinelli & Jennifer Cox
9:00 am Immunization Update 2024 Crystal Sharp
10:00 am Trauma Informed Care Mandy Davis
11:00 am Updates in MAT Therapy Amy Cervan & Amber Taylor
Noon Lunch/Exhibitors
1:00 pm New Treatments for Migraine Headache Jane Ishmael
2:00 pm What to Expect When You Are Inspected by DEA Rica Rachut & Thaer Qasem
3:00 pm Keeping Cannabis Users Safe Korin Richardson
4:00 pm Psychoactive Substances Stacy Ramirez
5:00-7:00 pm Social event in Exhibitor Hall
SUNDAY, MARCH 3, 2024
7:00 am Breakfast/Exhibitors
8:00 am Oregon Board of Pharmacy Law Update Jennifer L. Davis & Katie Baldwin
9:00 am Respiratory Syncytial Virus (RSV): Latest Updates on Prevention Amanda Bair
10:00 am Current Topics in the 340B Program Joshua Free
11:00 am New Drug Update Natalea Braden-Suchy
Noon Lunch/Exhibitors
1:00 pm PBM Reform: Essential Updates and Imperative Pharmacist Engagement Paige Clark, Michele Belcher, Plus 1 more
2:00 pm Upgrade Your Internal Operating System to Co-Create a Better Reality Susan Morley & Anita J. Cleven
3:00 pm Clinical Pearls – Pediatric Vaccine Administration Victor Abreu
3:20 pm Clinical Pearls – Titrating and Switching Between GLP-1 Agonists Sarah Salomone
3:40 pm Clinical Pearls – 2023 Asthma Guidelines Updates – What You Need to Know Mal Trombetta

 

 

 

 

 

 

 

 

 

 

 

 

 

Target Audience: Pharmacists and Pharmacy Technicians
Total Credits Available: 15 1-hour activities for up to 1.5 CEUs
Activity Type(s): Knowledge and Application-based
Conflict of Interest Disclosures: Dr. Natalia Puccinelli own stocks in Eli Lilly, Oramed Pharmaceuticals, Novo Nordisk, and Panbela Therapeutics. These relationships have been mitigated for this program. All other speakers and planners for this program have no financial relationships with ineligible companies to disclose.

 

Title: Leveraging Technology in Diabetes Management: A Guide to Continuous Glucose Monitoring (CGM)
UAN: 0036-9999-24-101-L01-P and 0036-9999-24-102-L01-T
Date & Time: 3/2/24, 8:00-9:00 am
Speakers: Natalia Puccinelli, PharmD, BCACP, BC-ADM, Community Health Centers of Lane County, Clinical Pharmacist; Jennifer Cox, PharmD, BCACP, NW Medical Homes, Clinical Pharmacist
Audience: RPh and CPT
Activity-Type: Application-based for RPh; Knowledge-based for CPT
Topic Designation: Disease State Management/Drug Therapy
Credit Hours: 1.0 (0.1 CEUs)
RPh Learning Objectives:

  1. Discuss the value of continuous glucose monitoring
  2. Distinguish key differences among the available CGM systems
  3. Identify ideal CGM candidates
  4. Analyze CGM metrics and data analysis
  5. Examine case studies to demonstrate application of CGM in clinical practice

CPT Learning Objectives:

  1. Discuss the value of continuous glucose monitoring
  2. Distinguish key differences among the available CGM systems
  3. Identify ideal CGM candidates

 

Title: Immunization Update 2024
UAN: 0036-9999-24-103-L06-P/T
Date & Time: 3/2/24, 9:00-10:00 am
Speakers: Crystal Sharp, PharmD, MBA, Fred Meyer, Pharmacy Manager
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Immunizations
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. Recognize recent updates to the CDC’s immunization schedules and gain knowledge about new vaccines on the market
  2. Discuss strategies to optimize your vaccine workflow and identify potential vaccine related safety mishaps
  3. Review changes to Oregon’s pharmacist immunization protocols
  4. Describe how to participate and/or provide feedback on existing Oregon pharmacist immunization protocols

 

Title: Trauma Informed Care
UAN: 0036-9999-24-104-L04-P/T
Date & Time: 3/2/24, 10:00-11:00 am
Speakers: Mandy Davis, LCSW, PhD, Trauma Informed Oregon, Director
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Pharmacy Administration (Cultural Competence)
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. Define “trauma informed care” and explain why it is important
  2. Name the principles of TIC
  3. Identify up to 3 ways to apply trauma informed approaches
  4. Identify up to 3 ways toxic stress and trauma show up in the workplace

 

Title: Updates in MAT Therapy
UAN: 0036-9999-24-105-L08-P/T
Date & Time: 3/2/24, 11:00-12:00 pm
Speakers: Amber Taylor, PharmD, Rogue Community Health, Director of Pharmacy; Amy Cervan, PharmD, Rogue Community Health, Senior Director of Pharmacy
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Opioids/Pain Management/Substance Use Disorder
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. Describe what Medication-Assisted Treatment (MAT) is for Opioid and Alcohol Use Disorder
  2. Define the different roles important to a successful MAT team
  3. Identify the correlation of mental health disorders in patients with SUD
  4. Discuss the different medication treatment options for SUD in Opioid and Alcohol Use Disorder
  5. Recognize the role of pharmacy in supporting MAT teams and patients with SUD

 

Title: New Treatments for Migraine Headache
UAN: 0036-9999-24-106-L01-P/T
Date & Time: 3/2/24, 1:00-2:00 pm
Speakers: Jane Ishmael, PhD, OSU College of Pharmacy, Professor of Pharmacology
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Disease State Management/Drug Therapy
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. Identify the mechanism of action of recently-approved medications for migraine headache
  2. Describe differences between acute and preventative treatment strategies for migraine headache
  3. Explain the efficacy and safety of medicines that have recently been approved for the treatment of migraine headache

 

Title: What to Expect When You Are Inspected by DEA
UAN: 0036-9999-24-107-L03-P/T
Date & Time: 3/2/24, 2:00-3:00 pm
Speakers: Rica Rachut, Drug Enforcement Administration, Acting Group Supervisor; Thaer Qasem, Drug Enforcement Administration, Drug Enforcement Investigator Diversion Investigator
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Law Related to Pharmacy Practice
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. Explain the federal recordkeeping regulations for pharmacies handling pharmaceutical controlled substances
  2. Recognize the importance of due diligence when operating a pharmacy
  3. Describe what to expect when DEA initiates an administrative inspection of a registered pharmacy
  4. Discuss the national opioid crisis

 

Title: Keeping Cannabis Users Safe
UAN: 0036-9999-24-108-L05-P/T
Date & Time: 3/2/24, 3:00-4:00 pm
Speakers: Korin Richardson, PharmD, BCPP, VA Southern Oregon Rehabilitation Clinics and Center, Clinical Psychiatric Pharmacist
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Patient Safety
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. Discuss general cannabis pharmacotherapy including hemp vs marijuana
  2. List the qualifying indications for medical marijuana use in Oregon
  3. Discuss safety concerns related to cannabis use
  4. Describe potential behavioral and medical effects of cannabis use
  5. Identify current concerns related to both purity and potency of cannabis

 

Title: Psychoactive Substances
UAN: 0036-9999-24-109-L01-P/T
Date & Time: 3/2/24, 4:00-5:00 pm
Speakers: Stacy Ramirez, PharmD, OSU College of Pharmacy, Clinical Assistant Professor, Community Health Clinic of Benton and Linn Counties, Director of Pharmacy/Clinical Pharmacist
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Disease State Management/Drug Therapy
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. Outline psychoactive substances with current or potential uses in clinical practice
  2. Review the pharmacology and potential risk/benefits of psychoactive substances
  3. Describe access of these substances in Oregon

 

Title: Oregon Board of Pharmacy Law Update
UAN: 0036-9999-24-110-L03-P/T
Date & Time: 3/3/24, 8:00-9:00 am
Speakers: Jennifer L. Davis, PharmD, MS, BCACP, RPh, Oregon Board of Pharmacy, Pharmacist Consultant; Katie Baldwin, RPh, Oregon Board of Pharmacy, Compliance Officer
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Law Related to Pharmacy Practice
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. Discuss new laws as well as current and proposed rules related to Oregon pharmacy practice
  2. Analyze recent legislative changes and proposed rule amendments affecting pharmacy practice in Oregon
  3. Review compliance expectations for existing laws and rules created to ensure safe and effective delivery of care
  4. Describe the purpose of inspections and what to expect during the inspection process
  5. Develop strategies to utilize the Board of Pharmacy’s available resources

 

Title: Respiratory Syncytial Virus (RSV): Latest Updates on Prevention
UAN: 0036-9999-24-111-L06-P/T
Date & Time: 3/3/24, 9:00-10:00 am
Speakers: Amanda Bair, PharmD, OHSU, Clinical Pharmacist
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Immunizations
Credit Hours: 1.0 (0.1 CEUs)
RPh Learning Objectives:

  1. Identify patients who are at high-risk for developing severe RSV
  2. Review historical treatment and preventative options for RSV
  3. Evaluate the clinical trials and ACIP recommendations for the newly available vaccines and monoclonal antibody for RSV prevention in older adults, pregnant women, and infants/children

CPT Learning Objectives:

  1. Recall which patient populations are at highest risk for developing a severe RSV infection
  2. Differentiate between the two FDA-approved RSV vaccines
  3. Discuss preventative options available for infants/pregnant women

 

Title: Current Topics in the 340B Program
UAN: 0036-9999-24-112-L03-P/T
Date & Time: 3/3/24, 10:00-11:00 am
Speakers: Joshua Free, PharmD, MBA, Nelco Advisory, President
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Law Related to Pharmacy Practice
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. Describe some of the current legal challenges in the 340B program
  2. Discuss perspectives in the 340B contract pharmacy dispute
  3. Explain key compliance concerns for 340B eligible pharmacotherapy clinics

 

Title: New Drug Update
UAN: 0036-9999-24-113-L01-P/T
Date & Time: 3/3/24, 11:00-12:00 pm
Speakers: Natalea Braden-Suchy, PharmD, BCACP
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Disease State Management/Drug Therapy
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. Identify new pharmacotherapy choices
  2. List indications, mechanism of action, common adverse effects, and significant drug interactions for those products
  3. Recognize safety concerns with selected new choices

 

Title: PBM Reform: Essential Updates and Imperative Pharmacist Engagement
UAN: 0036-9999-24-114-L04-P/T
Date & Time: 3/3/24, 1:00-2:00 pm
Speakers: Paige Clark, RPh; Michele Belcher, BPharm, RPh
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Pharmacy Administration
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. Recall recent updates in federal PBM reform
  2. List elements important to individual states regarding PBM reform
  3. Identify imperative pharmacist engagement components in the healthcare ecosystem

 

Title: Upgrade Your Internal Operating System to Co-Create a Better Reality
UAN: 0036-9999-24-115-L9—P/T
Date & Time: 3/3/24, 2:00-3:00 pm
Speakers: Anita J. Cleven, PharmD, RPh, Pacific University School of Pharmacy; Susan Morley, PharmD, MS, MBA, OSU College of Pharmacy, Senior Instructor I
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Additional Topic Areas
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. Describe what commonly holds people back from becoming their best selves
  2. Identify signs of a sophisticated internal operating system
  3. Discuss the window of tolerance and its impact in your life
  4. Recognize mindset-specific practices to update your internal operating system

 

Title: Clinical Pearls
UAN: 0036-9999-24-116-L01-P/T
Date & Time: 3/3/24, 3:00-5:00 pm
Speakers: Victor Abreu, RPh, OSU Community-Based Pharmacy Resident; Sarah Salomone, PharmD, PGY-1 Community-Based Pharmacy Resident, Albertsons-Safeway; Mal Trombetta, PharmD, OSU Community-Based Pharmacy Resident
Audience: RPh and CPT
Activity-Type: Knowledge-based
Topic Designation: Pharmacy Administration
Credit Hours: 1.0 (0.1 CEUs)
Learning Objectives:

  1. (Abreu) Recognize the recommended flu immunization schedules for pediatric populations
  2. (Abreu) Recognize common side effects, allergies, life-threatening interactions, and contraindications regarding flu immunization and how to report adverse reaction events
  3. (Salomone) Differentiate the titration schedules unique to each GLP-1 agonist, specifying the maximum dosage for each agent based on the associated indication
  4. (Salomone) Examine and investigate recommended strategies for transitioning patients between distinct GLP-1 agonists
  5. (Trombetta) Recognize changes to the GINA Guidelines and how they affect your practice
  6. (Trombetta) Define terminology in the updated GINA Guidelines such as AIR and MART

 

CANCELLATIONS:
Cancellations may be requested by phone, email, or online. Please note that refunds will be processed in the original form of payment. If you have any questions about our cancellation and refund policy, please call 503-582-9055 or email info@oregonpharmacy.org.

REFUNDS:

  •  Refunds requested up to 14 days prior to the event will be considered and processed for the full amount less the $50 processing fee and considering exceptions stated below.
  • Refunds requested less than 14 days prior to the event will not be considered or accepted.

 EXCEPTIONS:

  • Costs for printed presentation packets are not refundable once printed.
  • Costs for meals purchased as a conference add-on for self or guest(s) may only be refunded if allowed by the venue/caterer’s policy.
  • In the event of a natural disaster, local/national conflict, infectious disease outbreak, or other unforeseeable occurrence that limits the ability of OSPA to hold a conference, OSPA reserves the right to transition all or part of a conference to a virtual meeting.
    • In this situation, no refunds will be given, and the conference will proceed as planned in a virtual or hybrid in-person/virtual environment.
  • In the event of a natural disaster, local/national conflict, infectious disease outbreak, or other unforeseeable occurrence that limits the ability of OSPA to hold a conference, OSPA reserves the right to amend all parts of this return policy to keep the financial solvency of OSPA secure.
    • In this situation, the amount of refund considered will depend on how much OSPA itself was refunded from venues, caterers, etc.

Sponsors

Exhibitors




 

 

 ACPE Continuing Pharmacy Education

This program has been planned and implemented in accordance with the policies of the Accreditation Council on Pharmacy Education (ACPE) through the joint sponsorship of the Oregon State University College of Pharmacy and the Oregon State Pharmacy Association (OSPA). The Oregon State University College of Pharmacy is accredited by the Accreditation Council on Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians will receive ACPE Continuing Education Credit. An NABP e-Profile ID is required to receive CPE hours. An NABP e-Profile ID can be obtained at MyCPEMonitor.net. Statement of Credit shall be issued only after successful completion of the program. Successful completion is defined as: 1) Attending, in its entirety, the CPE activity or activities; 2) Participation in the pre-test administered by the presenter; 3) Completion of the online activity evaluation and post-test located at: http://pharmacy.oregonstate.edu/ce within 30 days of program attendance.

Statements of Credit will be uploaded to each participant’s NABP e-profile automatically within 48 hours of successful program completion. It is the participant’s responsibility to complete the online components within 30 days of program attendance to ensure awarding of credit. It is the participant’s responsibility to check CPE Monitor and ensure credits have successfully uploaded.

Details

Start:
March 2
End:
March 3
Event Category:

Organizer

OSPA

Venue

The Graduate Eugene
66 E 6th Ave.
Eugene, Oregon 97401
+ Google Map
View Venue Website